Panel Discussion | Tricuspid | Do we have the Right Tools to Address the Unmet Clinical Need?

Tuesday, March 11, 2025

10:00 AM - 10:20 AM ET

Panel Moderator(s)

Lawrence Biegelsen, MBA

Managing Director Medical Supplies & Devices
Wells Fargo
Short Hills, New Jersey, United States

No relationships to disclose
Rick Wise, CFA

Research Analyst
Stifel
New York, New York, United States

No relationships to disclose

Panel Discussant(s)

Steven F. Bolling, MD

Professor of Cardiac Surgery
University of Michigan Hospital
Ann Arbor, Michigan, United States

Disclosure(s): Tangent: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); xDOT: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Michael E. Bowdish, MD MS FACS FACC

Vice Chair and Clinical Chief
Cedars-Sinai Medical Center
Los Angeles, California, United States

Disclosure(s): No financial relationships to disclose
Ramon Quesada, MD, FACP, FACC, FSCAI

Medical Director of Interventional Cardiology, Structural Heart & Cardiac Research
Miami Cardiac & Vascular Institute
Miami, Florida, United States

No relationships to disclose
Lars Sondergaard, MD

Chief Medical Officer
Abbott Structural Heart
Santa Clara, California, United States

No relationships to disclose
Pradeep Yadav, MD

Director of Structural Interventions
Piedmont Atlanta Hospital
Atlanta, Georgia, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); DASI Simulations: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Lawrence Biegelsen, MBA: No financial relationships to disclose

Rick Wise, CFA: No financial relationships to disclose

Steven F. Bolling, MD: Tangent: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); xDOT: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Michael E. Bowdish, MD MS: No financial relationships to disclose

Ramon Quesada, MD, FACP, FACC, FSCAI: Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Lars Sondergaard, MD: Abbott Structural Heart, Medtronic, Boston Scientific: Employee (Ongoing)

Pradeep Yadav, MD: Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); DASI Simulations: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing)